| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
01-12-2023, 12:34 PM
|
#1 | |||
|
||||
|
Senior Member
|
There is an article in The Lancet proposing a reclassification of MS--abandoning the categories of RRMS, SPMS, RPMS, PPMS. Now ECTRIMS is conducting a Webinar about this proposed new method of classifying MS:
ECTRIMS Webinar: Redefining How MS is Classified Summary of the Lancet article: Multiple sclerosis progression: time for a new mechanism-driven framework - ScienceDirect
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, since 12/16/20 |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| mjff Webinar: “Is Exercise As Important As the Pills You Take?” January 2015 | Parkinson's Disease | |||
| Interesting webinar | Parkinson's Disease | |||
| PDF Webinar | Parkinson's Disease | |||
| Biomarkers--researcher webinar | Parkinson's Disease | |||
Webinar January 26 on reclassifying MS
Linear Mode
